BAY 85-8501
| CAS No. | 1161921-82-9 | Cat. No. | BCP44126 |
| Name | BAY 85-8501 | ||
| Synonyms | BAY85-8501; BAY-85-8501; BAY 858501; BAY858501; BAY-858501; | ||
| Formula | C22H17F3N4O3S | M. Wt | 474.46 |
| Description | BAY 85-8501 is a new, highly potent and selective neutrophil elastase inhibitor (IC50 for HNE = 0.065 nM, LipE = 7.2). BAY 85-8501 has shown in vivo efficacy in various preclinical animal models. BAY 85-8501 is currently being tested in clinical studies for the treatment of pulmonary diseases. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Elastase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.